Education

ScienceDirect
Mar 12, 2025
A rare presentation of pulmonary transthyretin amyloidosis
AbstractVirchow described amyloidosis in 1853. Amyloidosis is the extracellular deposition of an insoluble misfolded polymerized tetramer of fibrillary protein that…
Read more
ScienceDirect
Mar 10, 2025
Diagnosis and management of mixed-phenotype hereditary-transthyretin amyloidosis: A case-based, Canadian perspective
AbstractHereditary amyloid transthyretin variant (ATTRv) amyloidosis is a rare, life-threatening disease, characterized by the deposition of aggregated…
Read more
National Library of Medicine
Mar 07, 2025
Novel targeted therapies for immunoglobulin light chain amyloidosis: latest updates from the 2024 ASH annual meeting
AbstractImmunoglobulin light chain (AL) amyloidosis is an incurable disease caused by the accumulation and sedimentation of unstable free light chains produced by…
Read more
ScienceDirect
Feb 28, 2025
Knowledge Landscape and Hotspots of Research in Transthyretin Amyloid Cardiomyopathy: A Bibliometric Analysis
AbstractBackground: Transthyretin amyloid cardiomyopathy (ATTR-CM) is a progressive and frequently underdiagnosed cause of heart failure characterized by the…
Read more
MDPI
Feb 26, 2025
A General Overview of Transthyretin Cardiac Amyloidosis and Summary of Expert Opinions on Pre-Symptomatic Testing and Management of Asymptomatic Patients with a Focus on Transthyretin V122I
AbstractTransthyretin cardiac amyloidosis (TTR-CA) is a pathological condition characterized by the accumulation of misfolded transthyretin (TTR) protein in the…
Read more
National Library of Medicine
Feb 25, 2025
One-Year Echocardiographic Follow-Up in Transthyretin Cardiac Amyloidosis: Impact of Tafamidis Treatment
AbstractBackground/Objectives: Cardiac amyloidosis (CA) is a rare and severe multisystem disorder, associated with an average survival of approximately five years.…
Read more
Subscribe to